Brenda J. Hoffman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Brenda J. Hoffman has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
- Michael Bradley Wallace
Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA
13 shared publications Neven Hadzijahic
8 shared publications- Koji Matsuda
Department of Endoscopy, The Jikei University School of Medicine, Tokyo, Japan
7 shared publications Rig S. Patel
7 shared publicationsRobert Etemad
7 shared publicationsRobert H. Hawes
7 shared publications
Latest Publications
- 11 January 2015
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 60 (6) , 1645-1654
Discrimination of Normal and Esophageal Cancer Plasma Proteomes by MALDI-TOF Mass Spectrometry
Most patients presenting with symptoms of esophageal cancer (EC) have advanced disease. Even with resection, the cure rate is extremely low due to local recurrence and metastatic disease. Early detection and effective therapeutic intervention are essential to improve survival.
- 11 January 2015
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 60 (6) , 1645-1654
Discrimination of Normal and Esophageal Cancer Plasma Proteomes by MALDI-TOF Mass Spectrometry
Most patients presenting with symptoms of esophageal cancer (EC) have advanced disease. Even with resection, the cure rate is extremely low due to local recurrence and metastatic disease. Early detection and effective therapeutic intervention are essential to improve survival.
- 1 April 2012
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 75 (4) , AB199
Sa1552 A Novel Technique Using a Structure-to-Probe (STP) Ratio to Do Post-Hoc Measurements of Stored EUS Images
- 1 April 2012
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 75 (4) , AB199
Sa1552 A Novel Technique Using a Structure-to-Probe (STP) Ratio to Do Post-Hoc Measurements of Stored EUS Images
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Predicting Progression of Side Branch (SB) Intraductal Papillary Mucinous Neoplasm (IPMN)
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Predicting Progression of Side Branch (SB) Intraductal Papillary Mucinous Neoplasm (IPMN)
- 30 April 2010
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 71 (5) , AB130-AB131
683g: EUS-FNA Detection of Micrometastases and Survival of Resected Early Stage Lung Cancer
- 30 April 2010
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 71 (5) , AB130-AB131
683g: EUS-FNA Detection of Micrometastases and Survival of Resected Early Stage Lung Cancer
- 31 May 2009
- Published by Elsevier in Gastroenterology
- Vol. 136 (5) , -751-751
W1904 Discrimination of Normal and Esophageal Cancer Plasma Proteomes By MALDI-TOF Mass Spectrometry
- 31 May 2009
- Published by Elsevier in Gastroenterology
- Vol. 136 (5) , -751-751
W1904 Discrimination of Normal and Esophageal Cancer Plasma Proteomes By MALDI-TOF Mass Spectrometry
- 1 December 2005
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 50 (12) , 2255-2258
EUS Diagnosis of an Unusual Case of Pylephlebitis Mimicking Metastatic Pancreatic Cancer
- 1 December 2005
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 50 (12) , 2255-2258
EUS Diagnosis of an Unusual Case of Pylephlebitis Mimicking Metastatic Pancreatic Cancer
- Open Access
Is endosonography guided fine needle aspiration (EUS-FNA) for sarcoidosis as good as we think?
Background: Preliminary data show that endosonography guided fine needle aspiration (EUS-FNA) may be an accurate method for diagnosing sarcoidosis. However, these data were obtained in a small selected group of patients with a very high pretest probability of sarcoidosis. This retrospective study reports on the use of EUS-FNA in an unselected group of patients with mediastinal lymphadenopathy of unknown origin. Methods: The EUS database of a single tertiary referral centre was reviewed for patients who underwent EUS-FNA for mediastinal lymphadenopathy of unknown origin. Clinical presentation and imaging studies of each case were carefully reviewed and the diagnosis “sarcoidosis” or “no sarcoidosis” attributed if possible. The diagnoses were compared with the result of EUS-FNA. Results: One hundred and twenty four patients were investigated. In 35 cases EUS-FNA identified granulomas (group 1); in the other 89 cases (group 2) no granulomas were detected. The definite diagnoses in group 1 were sarcoidosis (n = 25), indefinite (n = 7), no sarcoidosis (n = 3). The definite diagnoses in group 2 were sarcoidosis (n = 3), indefinite (n = 9), no sarcoidosis (n = 77). Of the 77 cases with no sarcoidosis, 44 were diagnosed with other diseases. The other 33 showed non-specific changes in the FNA and sarcoidosis was excluded by negative non-EUS pathology (n = 17) and clinical presentation. The sensitivity and specificity for EUS-FNA were 89% (95% CI 82 to 94) and 96% (95% CI 91 to 98), respectively, after exclusion of the indefinite cases in both groups. Conclusions: EUS-FNA is an accurate method for diagnosing sarcoidosis in an unselected group of patients with mediastinal lymphadenopathy. The reported sensitivity and specificity must be appreciated in the context of the difficult and often incomplete clinical diagnosis of sarcoidosis.
Open AccessIs endosonography guided fine needle aspiration (EUS-FNA) for sarcoidosis as good as we think?
Background: Preliminary data show that endosonography guided fine needle aspiration (EUS-FNA) may be an accurate method for diagnosing sarcoidosis. However, these data were obtained in a small selected group of patients with a very high pretest probability of sarcoidosis. This retrospective study reports on the use of EUS-FNA in an unselected group of patients with mediastinal lymphadenopathy of unknown origin. Methods: The EUS database of a single tertiary referral centre was reviewed for patients who underwent EUS-FNA for mediastinal lymphadenopathy of unknown origin. Clinical presentation and imaging studies of each case were carefully reviewed and the diagnosis “sarcoidosis” or “no sarcoidosis” attributed if possible. The diagnoses were compared with the result of EUS-FNA. Results: One hundred and twenty four patients were investigated. In 35 cases EUS-FNA identified granulomas (group 1); in the other 89 cases (group 2) no granulomas were detected. The definite diagnoses in group 1 were sarcoidosis (n = 25), indefinite (n = 7), no sarcoidosis (n = 3). The definite diagnoses in group 2 were sarcoidosis (n = 3), indefinite (n = 9), no sarcoidosis (n = 77). Of the 77 cases with no sarcoidosis, 44 were diagnosed with other diseases. The other 33 showed non-specific changes in the FNA and sarcoidosis was excluded by negative non-EUS pathology (n = 17) and clinical presentation. The sensitivity and specificity for EUS-FNA were 89% (95% CI 82 to 94) and 96% (95% CI 91 to 98), respectively, after exclusion of the indefinite cases in both groups. Conclusions: EUS-FNA is an accurate method for diagnosing sarcoidosis in an unselected group of patients with mediastinal lymphadenopathy. The reported sensitivity and specificity must be appreciated in the context of the difficult and often incomplete clinical diagnosis of sarcoidosis.
- 1 April 2000
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 51 (4) , AB246
7020 Endoscopic ultrasound as a tool to detect subclinical portal hypertension: final results of a prospective study of endoscopic ultrasound findings in a consecutive series of drinkers and non-drinke 246 with no clinical evidence or other risk factors for liver disease.
- 1 April 2000
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 51 (4) , AB246
7020 Endoscopic ultrasound as a tool to detect subclinical portal hypertension: final results of a prospective study of endoscopic ultrasound findings in a consecutive series of drinkers and non-drinke 246 with no clinical evidence or other risk factors for liver disease.